Histological analysis confirmed the ameliorative effect of intestinal ATGL/CGI-58 deficiency on hepatic steatosis (Figure 2D), which might be attributable to 48% decreased plasma TG levels in the VLDL fraction (Figures 2E and 2F). The gene discussed is ABHD5; the disease is fatty liver disease.